Position in AMGN
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$18,292,853
+$555,039 QoQ
Shares Held
50,516
+0.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#397
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Harvest Fund Management Co., Ltd holds $61,466,678 across 9 Drug Manufacturers - General names. AMGN ranks #2 (29.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,480 | $19,766,608 | |
| 2 | AMGN |
Amgen Inc
This page
|
50,516 | $18,292,853 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
105,327 | $13,307,013 | |
| 4 | ABBV |
AbbVie Inc.
|
29,691 | $7,471,443 | |
| 5 | JNJ |
Johnson & Johnson
|
4,465 | $1,133,976 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,547 | $492,478 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,600 | $462,600 | |
| 8 | NVS |
Novartis AG
|
2,900 | $454,488 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,292,853 | 50,516 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $17,737,814 | 50,413 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $15,845,731 | 48,412 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $10,648,534 | 37,734 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,717,885 | 41,968 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $16,953,304 | 54,416 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $8,251,080 | 31,657 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $8,859,486 | 27,496 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,927,801 | 18,972 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,603,140 | 16,190 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,822,590 | 6,328 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $2,171,312 | 8,079 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $805,044 | 3,626 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $1,249,847 | 5,170 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,560,606 | 5,942 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $489,794 | 2,173 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $155,225 | 638 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $257,296 | 1,064 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $88,863 | 395 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $181,177 | 852 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $440,700 | 1,808 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $484,433 | 1,947 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $559,395 | 2,433 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,047,139 | 4,120 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $1,004,527 | 4,259 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $875,793 | 4,320 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||